Report

The Proliferation of Innovation: New Medicines and Technologies Transforming Patient Care

The Proliferation of Innovation: New Medicines and Technologies Transforming Patient Care

Pages 31 Pages

This report highlights how innovation in medicines, diagnostics, digital health, and AI is reshaping healthcare globally. Between 2019–2023, over 350 new active substances launched, with oncology, rare diseases, and immunology leading growth. Digital health adoption is expanding, especially in diagnostics, wearables, and AI-driven care. Challenges include affordability, sustainability, and ensuring equitable access. The report underscores the importance of balancing innovation with health system capacity, supporting patient outcomes while addressing disparities.

Join for free to read